SG11201706511TA - Benzoxaborole compounds and uses thereof - Google Patents

Benzoxaborole compounds and uses thereof

Info

Publication number: SG11201706511TA
Authority: SG; Singapore
Prior art keywords: benzoxaborole compounds; benzoxaborole; compounds
Prior art date: 2015-02-12

Application number

SG11201706511TA

Other languages

English (en)

Inventor

M R K Alley (Dickon)

David Barros-Aguirre

Ilaria Giordano

Vincent Hernandez

Xianfeng Li

Jacob J Plattner

Original Assignee

Glaxosmithkline Intellectual Property (No 2) Ltd

Anacor Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-02-12

Filing date

2016-02-12

Publication date

2017-09-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55409879&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201706511T(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-02-12 Application filed by Glaxosmithkline Intellectual Property (No 2) Ltd, Anacor Pharmaceuticals Inc filed Critical Glaxosmithkline Intellectual Property (No 2) Ltd

2017-09-28 Publication of SG11201706511TA publication Critical patent/SG11201706511TA/en

Links

GDMJXXLVTYSBBE-UHFFFAOYSA-N 1,2-benzoxaborole Chemical class C1=CC=C2OB=CC2=C1 GDMJXXLVTYSBBE-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Virology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Physical Education & Sports Medicine (AREA)
Reproductive Health (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SG11201706511TA 2015-02-12 2016-02-12 Benzoxaborole compounds and uses thereof SG11201706511TA (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP15382056		2015-02-12
EP15382055		2015-02-12
EP15382054		2015-02-12
PCT/IB2016/050776 WO2016128949A1 (en)	2015-02-12	2016-02-12	Benzoxaborole compounds and uses thereof

Publications (1)

Publication Number	Publication Date
SG11201706511TA true SG11201706511TA (en)	2017-09-28

Family

ID=55409879

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SG11201706511TA SG11201706511TA (en)	2015-02-12	2016-02-12	Benzoxaborole compounds and uses thereof
SG11201706510YA SG11201706510YA (en)	2015-02-12	2016-02-12	4 -substituted benzoxaborole compounds and uses thereof

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SG11201706510YA SG11201706510YA (en)	2015-02-12	2016-02-12	4 -substituted benzoxaborole compounds and uses thereof

Country Status (35)

Country	Link
US (3)	US10774096B2 (zh)
EP (2)	EP3256479B1 (zh)
JP (2)	JP2018506540A (zh)
KR (2)	KR20170117158A (zh)
CN (2)	CN107531730B (zh)
AU (3)	AU2016217507B2 (zh)
BR (2)	BR112017017213A2 (zh)
CA (2)	CA2976030C (zh)
CL (2)	CL2017002060A1 (zh)
CO (2)	CO2017008816A2 (zh)
CR (2)	CR20170371A (zh)
CY (1)	CY1123687T1 (zh)
DK (1)	DK3256479T3 (zh)
DO (2)	DOP2017000189A (zh)
EA (2)	EA036516B1 (zh)
ES (1)	ES2821951T3 (zh)
HR (1)	HRP20201597T1 (zh)
HU (1)	HUE051113T2 (zh)
IL (2)	IL253865A0 (zh)
LT (1)	LT3256479T (zh)
MA (2)	MA41494B1 (zh)
MX (2)	MX2017010413A (zh)
MY (1)	MY194004A (zh)
NZ (1)	NZ734379A (zh)
PE (2)	PE20171348A1 (zh)
PH (2)	PH12017501427A1 (zh)
PL (1)	PL3256479T3 (zh)
PT (1)	PT3256479T (zh)
RS (1)	RS60885B1 (zh)
SG (2)	SG11201706511TA (zh)
SI (1)	SI3256479T1 (zh)
TW (2)	TWI730953B (zh)
UA (1)	UA120527C2 (zh)
WO (2)	WO2016128949A1 (zh)
ZA (1)	ZA201705456B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6499175B2 (ja) *	2013-08-09	2019-04-10	グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙ（Ｎｏ．２）Ｌｉｍｉｔｅｄ	三環式ベンゾキサボロール化合物及びその使用
HRP20221212T1 (hr)	2017-05-08	2022-12-09	Glaxosmithkline Intellectual Property Development Limited	Sanfetrinem ili njegova sol ili esteri za uporabu u liječenju mikobakterijskih infekcija
WO2019108982A1 (en)	2017-11-30	2019-06-06	Boragen, Inc.	Benzoxaborole compounds and formulations thereof
CA3148168A1 (en)	2018-08-18	2020-02-27	Chun Yu Liu	Solid forms of substituted benzoxaborole and compositions thereof
CN110441344B (zh) *	2019-06-25	2020-09-29	北京大学	一种基于固体核磁共振技术检测rna结构的方法
WO2023246841A1 (en) *	2022-06-23	2023-12-28	Shanghai Micurx Pharmaceutical Co., Ltd.	Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same
AU2023287063A1 (en) *	2022-06-23	2024-05-30	Shanghai Micurx Pharmaceutical Co., Ltd.	Prodrugs of boron compounds and their use in treating bacterial infections

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9411587D0 (en) *	1994-06-09	1994-08-03	Zeneca Ltd	Compound, composition and use
AU4967997A (en)	1996-12-02	1998-06-29	Chisso Corporation	Optically active nitro alcohol derivatives, optically active amino alcohol derivates, and process for preparing the same
CA2507908A1 (en)	2002-12-02	2004-06-17	Solvias Ag	Catalytic hydrogeneration of carbon-heteroatom double bonds
PL2987796T3 (pl)	2005-02-16	2018-12-31	Anacor Pharmaceuticals, Inc.	Fluorowco-podstawione boronoftalidy do leczenia zakażeń
EP1856113B1 (en)	2005-03-08	2016-01-06	Agency for Science, Technology and Research	Chiral bisoxazoline catalysts
RU2008131324A (ru)	2005-12-30	2010-02-10	Анакор Фармасьютикалз, Инк. (Us)	Борсодержащие малые молекулы
TWM325238U (en) *	2006-12-29	2008-01-11	Universal Scient Ind Co Ltd	Voltage regulator and voltage regulating system
KR100848491B1 (ko)	2007-01-16	2008-07-28	영진약품공업주식회사	베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar)	2007-06-20	2019-10-20	Anacor Pharmaceuticals Inc	جزيئات صغيرة تحتوي على البورون
SG172040A1 (en)	2008-12-17	2011-07-28	Anacor Pharmaceuticals Inc	Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol
WO2011037731A1 (en) *	2009-09-25	2011-03-31	Anacor Pharmaceuticals, Inc.	Boron containing small molecules
AU2011237681B2 (en)	2010-04-07	2015-01-22	Glaxosmithkline Llc	Process for preparing benzoxaboroles
CN108610356B (zh)	2010-09-07	2021-02-26	阿纳科制药公司	苯并氧杂硼杂环戊二烯衍生物用于治疗细菌感染
US8530452B2 (en)	2011-12-22	2013-09-10	Micurx Pharmaceuticals, Inc.	Tricyclic boron compounds for antimicrobial therapy
CN102739587B (zh)	2012-06-16	2014-05-21	天地融科技股份有限公司	音频数据传输方法
KR101636431B1 (ko)	2013-07-30	2016-07-05	동아에스티 주식회사	트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
JP6499175B2 (ja) *	2013-08-09	2019-04-10	グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙ（Ｎｏ．２）Ｌｉｍｉｔｅｄ	三環式ベンゾキサボロール化合物及びその使用

2016
- 2016-02-11 MA MA41494A patent/MA41494B1/fr unknown
- 2016-02-11 MA MA041495A patent/MA41495A/fr unknown
- 2016-02-12 CN CN201680021538.8A patent/CN107531730B/zh active Active
- 2016-02-12 CN CN201680021488.3A patent/CN107548398A/zh active Pending
- 2016-02-12 PE PE2017001401A patent/PE20171348A1/es not_active Application Discontinuation
- 2016-02-12 JP JP2017542053A patent/JP2018506540A/ja active Pending
- 2016-02-12 US US15/550,693 patent/US10774096B2/en active Active
- 2016-02-12 WO PCT/IB2016/050776 patent/WO2016128949A1/en active Application Filing
- 2016-02-12 PT PT167060029T patent/PT3256479T/pt unknown
- 2016-02-12 MY MYPI2017702943A patent/MY194004A/en unknown
- 2016-02-12 SG SG11201706511TA patent/SG11201706511TA/en unknown
- 2016-02-12 PL PL16706002T patent/PL3256479T3/pl unknown
- 2016-02-12 AU AU2016217507A patent/AU2016217507B2/en active Active
- 2016-02-12 US US15/550,658 patent/US20180037595A1/en not_active Abandoned
- 2016-02-12 EP EP16706002.9A patent/EP3256479B1/en active Active
- 2016-02-12 BR BR112017017213-5A patent/BR112017017213A2/pt not_active Application Discontinuation
- 2016-02-12 PE PE2017001400A patent/PE20171432A1/es not_active Application Discontinuation
- 2016-02-12 EP EP16706003.7A patent/EP3256480A1/en not_active Withdrawn
- 2016-02-12 WO PCT/IB2016/050775 patent/WO2016128948A1/en active Application Filing
- 2016-02-12 MX MX2017010413A patent/MX2017010413A/es unknown
- 2016-02-12 HU HUE16706002A patent/HUE051113T2/hu unknown
- 2016-02-12 NZ NZ734379A patent/NZ734379A/en unknown
- 2016-02-12 UA UAA201708405A patent/UA120527C2/uk unknown
- 2016-02-12 LT LTEP16706002.9T patent/LT3256479T/lt unknown
- 2016-02-12 DK DK16706002.9T patent/DK3256479T3/da active
- 2016-02-12 RS RS20201204A patent/RS60885B1/sr unknown
- 2016-02-12 BR BR112017017211-9A patent/BR112017017211B1/pt active IP Right Grant
- 2016-02-12 CA CA2976030A patent/CA2976030C/en active Active
- 2016-02-12 MX MX2017010414A patent/MX2017010414A/es unknown
- 2016-02-12 EA EA201791671A patent/EA036516B1/ru unknown
- 2016-02-12 CR CR20170371A patent/CR20170371A/es unknown
- 2016-02-12 AU AU2016217508A patent/AU2016217508A1/en not_active Abandoned
- 2016-02-12 EA EA201791667A patent/EA201791667A1/ru unknown
- 2016-02-12 SI SI201630941T patent/SI3256479T1/sl unknown
- 2016-02-12 SG SG11201706510YA patent/SG11201706510YA/en unknown
- 2016-02-12 CR CR20170372A patent/CR20170372A/es unknown
- 2016-02-12 JP JP2017541999A patent/JP6771472B2/ja active Active
- 2016-02-12 CA CA2976308A patent/CA2976308A1/en not_active Abandoned
- 2016-02-12 KR KR1020177025539A patent/KR20170117158A/ko not_active Application Discontinuation
- 2016-02-12 ES ES16706002T patent/ES2821951T3/es active Active
- 2016-02-12 KR KR1020177025535A patent/KR20170117156A/ko unknown
- 2016-02-15 TW TW105104376A patent/TWI730953B/zh not_active IP Right Cessation
- 2016-02-15 TW TW105104422A patent/TW201702250A/zh unknown
2017
- 2017-08-07 IL IL253865A patent/IL253865A0/en unknown
- 2017-08-07 IL IL253864A patent/IL253864B/en unknown
- 2017-08-09 PH PH12017501427A patent/PH12017501427A1/en unknown
- 2017-08-09 PH PH12017501428A patent/PH12017501428A1/en unknown
- 2017-08-10 DO DO2017000189A patent/DOP2017000189A/es unknown
- 2017-08-10 DO DO2017000188A patent/DOP2017000188A/es unknown
- 2017-08-11 ZA ZA201705456A patent/ZA201705456B/en unknown
- 2017-08-11 CL CL2017002060A patent/CL2017002060A1/es unknown
- 2017-08-11 CL CL2017002059A patent/CL2017002059A1/es unknown
- 2017-08-29 CO CONC2017/0008816A patent/CO2017008816A2/es unknown
- 2017-08-29 CO CONC2017/0008809A patent/CO2017008809A2/es unknown
2020
- 2020-09-11 US US17/018,301 patent/US11214582B2/en active Active
- 2020-10-07 HR HRP20201597TT patent/HRP20201597T1/hr unknown
- 2020-10-14 AU AU2020256369A patent/AU2020256369A1/en not_active Abandoned
- 2020-10-15 CY CY20201100978T patent/CY1123687T1/el unknown

Also Published As

Publication number	Publication date
US11214582B2 (en)	2022-01-04
CN107531730B (zh)	2020-08-07
CY1123687T1 (el)	2022-03-24
HUE051113T2 (hu)	2021-01-28
US10774096B2 (en)	2020-09-15
CA2976308A1 (en)	2016-08-18
DOP2017000188A (es)	2017-09-15
CL2017002059A1 (es)	2018-03-16
DOP2017000189A (es)	2018-02-15
MA41494B1 (fr)	2020-10-28
EA201791667A1 (ru)	2018-02-28
CA2976030C (en)	2023-09-26
CO2017008809A2 (es)	2017-11-10
EP3256480A1 (en)	2017-12-20
EP3256479A1 (en)	2017-12-20
CL2017002060A1 (es)	2018-03-16
BR112017017211B1 (pt)	2023-04-25
AU2016217508A1 (en)	2017-09-28
LT3256479T (lt)	2020-12-28
MA41495A (fr)	2017-12-19
TW201702250A (zh)	2017-01-16
CN107531730A (zh)	2018-01-02
MA41494A (fr)	2017-12-19
US20210053996A1 (en)	2021-02-25
JP2018506540A (ja)	2018-03-08
MX2017010414A (es)	2018-05-11
PH12017501427A1 (en)	2018-01-15
IL253865A0 (en)	2017-10-31
EA201791671A1 (ru)	2018-02-28
EA036516B1 (ru)	2020-11-18
CR20170372A (es)	2017-10-19
WO2016128948A1 (en)	2016-08-18
PE20171432A1 (es)	2017-09-26
CN107548398A (zh)	2018-01-05
WO2016128949A1 (en)	2016-08-18
PH12017501428A1 (en)	2018-01-15
BR112017017211A2 (pt)	2018-04-03
IL253864B (en)	2021-07-29
MX2017010413A (es)	2018-05-11
UA120527C2 (uk)	2019-12-26
EP3256479B1 (en)	2020-07-29
PT3256479T (pt)	2020-10-22
SI3256479T1 (sl)	2020-11-30
ES2821951T3 (es)	2021-04-28
PE20171348A1 (es)	2017-09-13
TW201643173A (zh)	2016-12-16
HRP20201597T1 (hr)	2020-12-25
KR20170117156A (ko)	2017-10-20
RS60885B1 (sr)	2020-11-30
AU2016217507A1 (en)	2017-09-28
JP6771472B2 (ja)	2020-10-21
MY194004A (en)	2022-11-07
BR112017017213A2 (pt)	2018-04-03
US20180037595A1 (en)	2018-02-08
ZA201705456B (en)	2019-10-30
DK3256479T3 (da)	2020-11-02
KR20170117158A (ko)	2017-10-20
TWI730953B (zh)	2021-06-21
PL3256479T3 (pl)	2021-06-14
IL253864A0 (en)	2017-09-28
SG11201706510YA (en)	2017-09-28
AU2016217507B2 (en)	2019-03-14
CA2976030A1 (en)	2016-08-18
CO2017008816A2 (es)	2017-11-10
US20180044353A1 (en)	2018-02-15
CR20170371A (es)	2018-01-22
AU2020256369A1 (en)	2020-11-12
JP2018506538A (ja)	2018-03-08
NZ734379A (en)	2023-06-30

Publication	Publication Date	Title
ZA201804070B (en)	2021-10-27	Eif4-a-inhibiting compounds and methods related thereto
SG11201706029VA (en)	2017-08-30	Anti-senescence compounds and uses thereof
HK1246780A1 (zh)	2018-09-14	氮雜-吡啶酮化合物及其用途
ZA201705456B (en)	2019-10-30	Benzoxaborole compounds and uses thereof
HK1257539A1 (zh)	2019-10-25	新的化合物及其用途
GB201504763D0 (en)	2015-05-06	Compounds and uses
GB201616439D0 (en)	2016-11-09	Compounds and uses
HK1247122A1 (zh)	2018-09-21	組合及其用途
GB201507753D0 (en)	2015-06-17	New compounds and uses
IL254241A0 (en)	2017-10-31	Etv2 and its uses
HK1250915A1 (zh)	2019-01-18	組合物和其用途
IL253459A0 (en)	2017-09-28	Isoergoline compounds and their uses
GB201718875D0 (en)	2017-12-27	Autophagy-inhibiting compounds and uses thereof
GB201501593D0 (en)	2015-03-18	New compounds and processes
GB201614224D0 (en)	2016-10-05	Compounds and uses thereof
IL258458B (en)	2021-01-31	Peroxyhemiacetal profragrant and proflavor compounds
GB2543375B (en)	2020-01-22	Compounds and their uses
GB201614874D0 (en)	2016-10-19	New compounds and uses
GB201621467D0 (en)	2017-02-01	Modified bulgeomers
GB201616374D0 (en)	2016-11-09	Modified bulgeomers
GB201614858D0 (en)	2016-10-19	Modified Bulgeomers
GB201507752D0 (en)	2015-06-17	New compounds and uses
GB201514770D0 (en)	2015-09-30	Compounds and their use
GB201602572D0 (en)	2016-03-30	New compound and uses
GB201516922D0 (en)	2015-11-11	New processes and compounds